Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
581 | BAX | BCL2 associated X, apoptosis regulator | |
842 | CASP9 | caspase 9 | |
847 | CAT | catalase | |
1116 | CHI3L1 | chitinase 3 like 1 | |
1605 | DAG1 | dystroglycan 1 | |
1906 | EDN1 | endothelin 1 | |
2034 | EPAS1 | endothelial PAS domain protein 1 | |
2321 | FLT1 | fms related receptor tyrosine kinase 1 | |
3091 | HIF1A | hypoxia inducible factor 1 subunit alpha | |
3557 | IL1RN | interleukin 1 receptor antagonist |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
12028 | Bax | BCL2-associated X protein | |
12371 | Casp9 | caspase 9 | |
12654 | Chi3l1 | chitinase 3 like 1 | |
13138 | Dag1 | dystroglycan 1 | |
14254 | Flt1 | FMS-like tyrosine kinase 1 | |
16181 | Il1rn | interleukin 1 receptor antagonist | |
17195 | Mbl2 | mannose-binding lectin (protein C) 2 | |
17829 | Muc1 | mucin 1, transmembrane | |
20388 | Sftpb | surfactant associated protein B | |
20390 | Sftpd | surfactant associated protein D |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
24617 | Serpine1 | serpin family E member 1 | |
24773 | Sftpa1 | surfactant protein A1 | |
24835 | Tnf | tumor necrosis factor | |
24842 | Tp53 | tumor protein p53 | |
25350 | Sftpd | surfactant protein D | |
60582 | Il1rn | interleukin 1 receptor antagonist | |
89824 | Chi3l1 | chitinase 3 like 1 | |
192155 | Sftpb | surfactant protein B |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
31926 | Idgf4 | Imaginal disc growth factor 4 | |
34978 | Idgf1 | Imaginal disc growth factor 1 | |
34979 | Idgf2 | Imaginal disc growth factor 2 | |
34981 | Idgf3 | Imaginal disc growth factor 3 | |
36773 | Dg | Dystroglycan | |
36868 | Idgf6 | Imaginal disc growth factor 6 | |
37104 | Idgf5 | Imaginal disc growth factor 5 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024